Trial · NCT07902622
Pakistan Arthritis and Connective Tissue Disease Network - Systemic Lupus Erythematosus
NCT07902622, Recruiting, Foundation University Islamabad
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Pakistan Arthritis and Connective Tissue Disease Network - Systemic Lupus Erythematosus. Trials, record NCT07902622. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07902622
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Pakistan Arthritis and Connective Tissue Disease Network - Systemic Lupus Erythematosus
- NCT number
- NCT07902622
- Status
- Recruiting
- Enrollment
- 3,000 participants, estimated
- Lead sponsor
- Foundation University Islamabad
- Conditions
- SLE - Systemic Lupus Erythematosus
- Interventions
- no active ingredient
- First posted
- 2026-10-29
- Last updated
- 2026-10-29
Source ClinicalTrials.gov
Registered outcomes3
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Characterisation of SLE phenotype in indigenous poputation | 10 years | To characterise the parents of SLE clinical features in the Pakistani population, including clinical characteristics, parents of organ involvement and disease severity |
| Secondary | Assessment of treatment patterns and outcomes | 10 years | We intend to evaluate the treatment modalities and their effectiveness in controlling disease activity and preventing complications. Through longitudinal follow-up assessments, we will monitor treatment adherence, disease progression, and patient-reported outcomes, thereby offering valuable insights into real-world lupus management. |
| Secondary | Identification of factors influencing disease course and treatment response | 10 years | To identify and evaluate demographic, clinical, serological, genetic, environmental, and treatment-related factors that influence disease progression, activity, flare frequency, organ damage, and response to therapy |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers3
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07902622
GET https://conductscience.org/api/trials/v1/NCT07902622/registered